Janssen Pharmaceutica is a pharmaceutical company headquartered in Beerse, Belgium. It was founded in 1953 by Paul Janssen. In 1961, Janssen Pharmaceutica was purchased by New Jersey-based American corporation Johnson & Johnson, and became part of Johnson & Johnson Pharmaceutical Research and ...
Explore Janssen's innovative medical research and development practices, and see how Janssen is dedicated to the well-being of patients around the world.
This site is published by Janssen Pharmaceuticals, Inc., which is solely responsible for its contents. Capitalized product names are trademarks of Janssen Pharmaceuticals, Inc. This information is intended for use by our customers, patients, and healthcare professionals in the United States only. Janssen Pharmaceuticals ...
JanssenMD™ provides free access to scientific and clinical information and services for a number of products marketed by the Janssen Pharmaceutical Companies of Johnson & Johnson. To access JanssenMD™ please click here. You may contact the Medical Information Center by visiting askjanssenmedinfo. com or by ...
Apalutamide, the first drug approved to treat non-metastatic castration-resistant prostate cancer, will also be the first NDA to have clinical summary report information made public under an FDA pilot program to increase transparency. Approvals Drug Approval Standards. Bookmark. 12 Feb 2018 ...
Janssen Pharmaceuticals, Inc. provides pharmaceutical services. The Company offers medicines for an array of health concerns in several therapeutic areas, including attention deficit hyperactivity disorder, general medicine, mental health, neurologics, pain management, and women's health.
Aug 22, 2017 ... Find information on drug affordability programs sponsored by Janssen as well as independent foundations and U.S. States. Learn how cost assistance programs can help people with limited or no health insurance afford their medications.
Janssen Pharmaceuticals, Inc. manufactures, markets and/or distributes more than 53 drugs in the U.S..